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Abstract
Background Intramyocardial haemorrhage (IMH) and micro-
vascular obstruction (MVO) represent reperfusion injury after
reperfused ST-elevation myocardial infarction (STEMI) with
prognostic impact and “hypointense core” (HIC) appearance
in T2-weighted images. We aimed to distinguish between
IMH and MVO by using T2
*-weighted cardiovascular mag-
netic resonance imaging (CMR) and analysed influencing
factors for IMH development.
Methods and results A total of 151 patients with acute STEMI
underwent CMR after primary angioplasty. T2-STIR se-
quences were used to identify HIC, late gadolinium enhance-
ment to visualise MVO and T2
*-weighted sequences to detect
IMH. IMH+/IMH− patients were compared considering in-
farct size, myocardial salvage, thrombolysis in myocardial
infarction (TIMI) flow, reperfusion time, ventricular volumes,
function and pre-interventional medication. Seventy-six pa-
tients (50 %) were IMH+, 82 (54 %) demonstrated HIC and
100 (66 %) MVO. IMH was detectable without HIC in 16 %,
without MVO in 5 % and HIC without MVO in 6 %. Multi-
variable analyses revealed that IMH was associated with
significant lower left ventricular ejection fraction and myocar-
dial salvage index, larger left ventricular volume and infarct
size. Patients with TIMI flow grade ≤1 before angioplasty
demonstrated IMH significantly more often.
Conclusions IMH is associated with impaired left ventricular
function and higher infarct size. T2 and HIC imaging showed
moderate agreement for IMH detection. T2
* imaging might be
the preferred CMR imaging method for comprehensive IMH
assessment.
Key Points
• Intramyocardial haemorrhage is a common finding in
patients with acute reperfused myocardial-infarction.
• T2
* imaging should be the preferred CMR method for
assessment of intramyocardial haemorrhage.
• Intramyocardial haemorrhage can be considered as an
important influencing factor on patient’s outcome.
Keywords Cardiacmagnetic resonance imaging . Acute
myocardial infarction . Haemorrhage .Microvascular
obstruction . Hypointense core
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Microvascular obstruction (MVO) and intramyocardial haem-
orrhage (IMH) are both frequent phenomena after reperfused
ST-elevation myocardial infarction (STEMI) [1, 2] and partly
represent reperfusion injury after primary percutaneous coro-
nary intervention (PPCI) [3]. MVO or the so-called no-reflow
phenomenon is caused by (1) embolization of particulate
debris, (2) release of vasoconstrictor, thrombogenic and in-
flammatory substances, and (3) structural collapse of the
capillary bed. MVO is associated with adverse ventricular
remodelling and worse prognosis [4]. Equally, IMH is con-
sidered as severe damage after revascularization by PPCI or
fibrinolysis which portends adverse prognosis [5]. Structural
and functional degradation of the microcirculation causes
extravasation of erythrocytes in the reperfused myocardium
[6, 7]. The pathophysiology of IMH is not fully understood
yet and it remains unresolved if IMH is a consequence of
MVO or vice versa and CMR and other imaging modalities
might help to better understand that phenomenon [8–14].
However, previous studies demonstrated that IMH presence
is an independent predictor of adverse left ventricular (LV)
remodelling and associated with larger infarct size [15].
O’Regan et al. demonstrated a positive correlation between
IMH and MVO and also IMH and infarct size in one of the
first human “in vivo” cardiac magnetic resonance (CMR)
studies using T2
*-weighted images [16]. T2
*-weighted CMR
is a sensitive and potentially more specific technique for
detecting IMH [8, 9]. The T2
* sequence was originally used
to illustrate cerebral haemorrhage [17, 18]. T2-weighted CMR
was utilized for quantifying oedema [3, 5], detecting the area
at risk (AAR) and calculating the myocardial salvage
[5,19–21]. In some cases a so-called hypointense core (HIC)
could additionally be visualised within the increased signal
intensity representing oedema. These regions of hypointense
signal have been demonstrated to correspond to histological
evidence of myocardial haemorrhage [8, 9]. However, studies
have also demonstrated that MVO may also cause
hypointense infarct cores [22]. Consequently, it does not seem
possible to differentiate if HIC illustrates MVO, IMH or both
by using exclusively T2-weighted sequences. To examine the
exact extent and prognostic impact of both findings as well as
influencing factors, it is crucial to precisely distinguish be-
tween IMH and MVO.
The aim of this study was therefore to evaluate the perfor-
mance of T2
* and HIC for detection of IMH and to assess the
relationship between IMH and clinical as well as CMR
markers of myocardial damage.
Material and methods
Patient population
A total of 151 consecutive patients (114 men, 37 women)
undergoing PPCI for STEMI at a tertiary care centre were
included between August 2009 and March 2010. All patients
presented with typical chest pain within 12 h (Table 1) and had
ST-segment elevation of ≥0.1 mV in ≥2 extremity leads or
≥0.2 mV in ≥2 precordial leads.
All patients gave written informed consent and the study
was approved by the local ethics committee. This analysis is a
substudy from the Abciximab Intracoronary versus intrave-
nously Drug Application in STEMI (AIDA STEMI) trial
(ClinicalTrial.gov Identifier NCT00712101) [23–25]. Exclu-
sion criteria for this CMR substudy were claustrophobia,
pregnancy, clinical instability, metallic implants, implanted
pacemakers or defibrillators.
The patients were categorized into two groups defined by
the presence or absence of IMH by using T2
* imaging. Fur-
thermore, cardiovascular risk factors, reperfusion times, med-
ication, culprit vessel, thrombolysis in myocardial infarction
(TIMI) flow grade before and after PPCI as well as LV
function and volumes were assessed to define possible
influencing factors of IMH (Table 1). For culprit lesion iden-
tification, the three main vessels—left anterior descending
artery, right coronary artery or left circumflex artery—were
also assessed for proximal, mid or distal lesion location. The
blood flow in the culprit vessel was graded according to the
TIMI flow grade before and after PPCI: grade 0, no reperfu-
sion; grade 1, low reperfusion; grade 2, partial reperfusion;
and grade 3, regular perfusion [26].
CMR imaging protocol
CMR was performed on a 1.5-Tesla scanner (Intera, Philips
Medical Systems, Best, the Netherlands) using a five-channel
phased-array surface coil within 8 days after PPCI.
– First, for functional analysis standard steady state free
precession (SSFP) sequences in breath-hold were
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obtained in four- and two-chamber view and a stack of
short-axis slices to cover the whole LV as described
previously [27–29]. The scan parameters were as follows:
repetition time (TR)=3.6 ms, echo time (TE)=1.8 ms, flip
angle=60°, slice thickness=8 mm, maximum field of
view (FOV)=400 mm, matrix 256×256, in-plane resolu-
tion <1.56×1.56×8 mm.
– Second, a stack of short-axis slices covering the whole
LV using a black blood T2-weighted short tau inversion
recovery (T2-STIR) sequence (TR=2 RR intervals,
TE=80 ms, flip angle=90°, slice thickness=10 mm,
maximum field of view (FOV)=370 mm, matrix
512×512, in-plane resolution <0.72×0.72×10 mm)
were acquired for detecting HIC within myocardial
oedema (Figs. 1a, 2a) and the area at risk (AAR)
by a free-breathing navigator technique.
– Third, the same slice orientation as for the T2-STIR image
was chosen for IMH detection in the middle of the myo-
cardial oedema, centrally located within the “area at risk”
of myocardial infarction (Figs. 1a, 2a). The T2
* sequence
with the following parameters was used: TR=
17 ms, TE=1, 3, 6, 8, 10, 12, 15 ms, flip angle=
Table 1 Patient characteristics















Age, years 61 (29–88) 60 (42–82) 62 (29–88) 0.36 0.85 0.988 0.962–1.014
Male, n (%) 114 (75) 61 (80) 53 (71) 0.17 1.86 1.69 0.800–3.580
Female, n (%) 37 (25) 15 (20) 22 (29)
Cardiovascular risk factors, n (%)
Current smoking 81 (54) 44 (59) 37 (49) 0.29 1.11 1.41 0.743–2.680
Arterial hypertension 103 (68) 52 (69) 51 (67) 0.96 0.00 1.02 0.514–2.020
Hypercholesterolaemia 52 (34) 20 (27) 32 (43) 0.03 4.40 0.480 0.242–0.953
Diabetes mellitus 32 (21) 18 (24) 14 (19) 0.45 0.57 1.35 0.620–2.970
Obesity 100 (66) 47 (62) 53 (71) 0.28 1.17 0.674 0.330–1.380
Positive medical family
history of CAD
52 (34) 30 (40) 22 (29) 0.19 1.71 1.57 0.800–3.090
Stroke 1 (0.7) 0 (0) 1 (1.3) 0.49 0.00 0.00
BMI, kg/m2 28.3±4 27.9±5 28.7±4 0.28 1.33 0.955 0.883–1.030
Reperfusion times, min
Pain-to-balloon time 263±196 281±194 245±198 0.26 0.27 1.01 0.982–1.030
Door-to-balloon time 30±13 31±13 30±14 0.61 1.23 1.00 1.000–1.000
Culprit vessel
LAD (proximal/mid/distal) 64 (29/31/4) 38 (19/17/2) 26 (10/14/2) 0.06 4.03 2.450 1.020–5.880
RCA (proximal/mid/distal) 59 (28/13/18) 22 (8/7/7) 37 (20/6/11) 0.01 7.31 0.281 0.112–0.706
LCX (proximal/mid/distal) 28 (5/20/3) 16 (3/11/2) 12 (2/9/1) 0.42 0.24 1.570 0.254–9.760
TIMI flow grade before PPCI
≤1, n (%)
92 (61) 54 (71) 38 (51) 0.02 5.26 2.23 1.120–4.440
TIMI flow grade after PPCI
<3, n (%)
16 (11) 6 (8) 10 (13) 0.55 1.28 0.540 0.186–1.570
Medication, n (%)
Beta-blocker 38 (25) 26 (34) 12 (16) 0.01 6.40 2.730 1.250–5.950
ACE inhibitor 25 (17) 11 (15) 14 (19) 0.49 0.48 0.737 0.311–1.750
AT-1 antagonist 22 (15) 9 (12) 13 (17) 0.34 0.91 0.641 0.256–1.600
Acetylsalicylic acid (ASA) 32 (21) 18 (24) 14 (19) 0.45 0.57 1.350 0.616–2.970
Clopidogrel 10 (7) 6 (8) 4 (5) 0.75 0.40 1.520 0.412–5.620
Statin 24 (16) 11 (15) 13 (17) 0.63 0.23 0.810 0.336–1.940
Hours between PPCI and CMR, n (%)
12–72 h 110 (73) 51 (67) 59 (79) 0.11 3.33 1.25 0.984–1.590
>72 h 41 (27) 25 (33) 16 (21)
Data are reported as mean ± SD or mean (minimum–maximum) if continuous and number (percentage) if categorical
OR odds ratio, CI confidence interval
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20°, slice thickness=10 mm, maximum field of view
(FOV)=240 mm, matrix 256×256, in-plane resolution
<0.94×0.94×10 mm. Images at seven different TE
(Figs. 1c, 2c) to calculate relaxation curves, a parameter
a b
c d
Fig. 1 IMH with MVO and
HIC: Short-axis CMR images
obtained 2 days after ischemic
reperfusion injury (pain-to-bal-
loon time 523 min) in a 53-year-
old man. In the anteroseptal
myocardium a large transmural
hyperintense region and HIC di-
rectly centrally located therein
(white arrows) are present on the
T2-STIR image (a); also, a major
hyperintense, contrast-enhancing
region (necrosis) with a clear
MVO (white arrows) within can
be visualised on the LGE image
(b) and a huge haemorrhage indi-
cated by a hypointense signal
(white arrows) can be seen on the
T2
*-weighted image at a TE of
15 ms (c) and within the T2
*-
weighted parameter image indi-
cating a T2
*-decay ≤20ms (d), the
threshold for haemorrhage in this
study [16]
Fig. 2 IMH without MVO and
HIC: Short axis CMR images
obtained 3 days after ischemic
reperfusion injury (pain-to-
balloon time 126 min) in a
74-year-old woman with an
occlusion of the circumflex artery
(LCX). a Demonstrates an
oedema in the inferior wall
without a HIC, b the LGE in the
inferior wall without any MVO
and c an obvious haemorrhage
(white arrows) on the T2
*-
weighted image at a TE of 15 ms
and within the T2
*-weighted
parameter image indicating a T2
*-
decay ≤20 ms, d the threshold for
haemorrhage in this study [16]
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image (Figs. 1d, 2d) and the T2
* decay [16] were obtained
from the parameter images. The occurrence or absence of
HIC with or without IMH was documented.
– Fourth and finally, late gadolinium enhancement (LGE)
images (Figs. 1b, 2b), sensitive for necrosis and MVO,
were acquired 10–15 min after intravenous administra-
tion of 0.15 mmol/kg Gd-DTPA by using a 3D-inversion
recovery gradient echo sequence (IR-GRE) with the fol-
lowing parameters: TR=2.9 ms, TE=1.5 ms, flip angle=
15°, slice thickness=10 mm (5 mm increment), maxi-
mum field of view (FOV)=370 mm, matrix 280×280,
in-plane resolution <1.32×1.32×10 mm.
CMR image analysis
All images were analysed using a dedicated workstation
(ViewForum R4.2V1C2 SP1, Software Release 2005-11-04,
Philips Medical Systems, Best, the Netherlands). LV volumes
and function for every patient were assessed by manually
outlining the endocardial contours of the LV from the SSFP
short axes sequences [5]. Short-axis T2-STIR sequences were
used to detect and to assess oedema and HIC (Figs. 1a, 2a). In
the LGE images the size of myocardial infarction was mea-
sured by using a threshold of two standard deviations of the
remote myocardium [5, 27]. In addition, the presence or
absence of MVO was documented (Figs. 1b, 2b). The sal-
vaged myocardium after PPCI was expressed by the myocar-
dial salvage index (MSI) calculated from the difference be-
tween oedema and necrosis divided by oedema [21]. IMHwas
considered as the region with decreased signal intensity in the
T2
*-weighted images based on the paramagnetic effects of
deoxyhaemoglobin and the reduction of the T2 time [30].
The used sequence provided T2
*-weighted images with the
described different TE additionally to a parameter image,
which was used to calculate the T2
* decay. According to
previous publications a decay at the T2
* parameter image
≤20 ms was considered as positive haemorrhage [16]
(Figs. 1d, 2d).
Statistical analysis
The study cohort was characterized by mean ± standard devi-
ation (SD) for continuous variables and by absolute and
relative frequencies for categorical variables. Continuous
variables were compared within the group of patients
with and without IMH by Student’s t test. Proportions
were compared by Pearson’s χ2 test (Tables 1, 3) and
Fisher’s exact test where appropriate.
Furthermore, a stepwise logistic regression analysis
was applied to identify possible predictors of the occur-
rence of IMH. All statistically significant clinical and
CMR variables of the univariate analyses (Tables 1, 3)
were included in the final multivariable model. All var-
iables selected by this algorithm were included in a final
model in order to get odds ratio estimates with the
corresponding 95 % confidence intervals (Table 4). All
tests performed were two-sided with a significance level
of 5 %. All statistical analyses were done by means of
SPSS software, version 16.0 for Windows.
Results
CMR was performed at a mean of 2.8 days (range 0–8 days)
after PPCI. The mean patient age of the 76 patients with IMH
was 60±11 years. There were no significant differences be-
tween patients with or without IMH concerning common
patient characteristics except for hypercholesterolaemia
(Table 1).
Functional and volumetric assessment
LV ejection fraction was significantly lower in patients with
IMH compared to those without (43.5±9.7 % vs. 51.1±8.6 %,
P<0.001) (Fig. 3). Patients with IMH also had a higher LV-
EDV (163±40 ml vs. 145±30 ml, P<0.01) and LV-ESV
(94±36 ml vs. 72±23 ml, P<0.001).
Comparison of T2
* mapping and T2-weighted imaging
for IMH detection
By using T2
* mapping IMH was detected in 50 % of all patients
(76/151). T2-weighted STIR images demonstrated HIC in 54 %
(82/151) and LGE images demonstratedMVO in 66% (100/151)
of all patients (Fig. 4).
p < 0.001




















Fig. 3 Relationship between LV ejection fraction and haemorrhage.
Patients with IMH had a significantly lower LV-EF than those without
IMH (43.5±9.7 % vs. 51.1±8.6 %, P<0.001)
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IMH occurred in the majority of patients (95 %; 72/
76) concomitantly with MVO (Fig. 1) and in only 5 %
(4/76) without (Fig. 2). When IMH and MVO were
present at the same time IMH occurred in centre areas
of the MVO. This phenomenon was observed especially
in large infarcts with large MVO areas. Additionally,
two of these four patients showed neither HIC nor a
concomitant MVO. HIC occurred in 6 % (5/82) of
patients without MVO.
Eighty-four percent (64/76) of patients with IMH
showed HIC in T2-STIR images (Table 2), whereas in
16 % (12/76) of patients IMH was not accompanied by
HIC.
Influencing factors for IMH occurrence
Differences could be demonstrated related to potential
influencing factors for the occurrence of IMH. The following
factors were analysed:
Location of occlusion
In 42 % (64/151) of patients the LAD, in 39 % (59/151) the
RCA and in 18.5 % (28/151) the LCX was occluded. The
culprit vessel in the majority of patients with IMH was the
LAD (50 % vs. 35 %, P=0.06) and without IMH was the
RCA (29 % vs. 49 %, P=0.01) (Table 1).
TIMI flow before PPCI
In IMH+ patients a TIMI flow≤1 before PPCI was signifi-
cantly more frequent than in IMH− patients (72 % vs. 54 %,
P<0.001) (Fig. 5).
Medication
A statistically significant difference in premedication of the
IMH+ vs. IMH− group could only be demonstrated with
regard to the intake of beta-blockers (34 % vs. 16 %;
P= 0.01) (Table 1). All other premedication, like
angiotensin-1 antagonists, ACE inhibitors or the intake of
acetylsalicylic acid (ASA), clopidogrel or statins were not
significantly different in both groups.
Infarct size/myocardial salvage index (MSI)
IMH+ patients had significantly larger infarcts (32.6±20.3 ml
vs. 12.9±9.5 ml, P<0.001) (Fig. 6) and a lower MSI (36 %±
21 % vs. 59 %±25 %, P<0.001) (Fig. 7).
Predictors of IMH
A stepwise logistic regression model was applied to identify
possible predictors of the occurrence of IMH (Tables 1, 3).
After the use of a univariate analysis several significant pa-
rameters were left for the multivariate analysis, like TIMI flow
grade before PPCI≤1 or the MSI. Nevertheless, the final
multivariate analysis revealed that patients with a HIC, or
even more likely with the presence of MVO, demonstrated a
high OR for the occurrence of IMH (Table 4). These results
again demonstrate the close relation between HIC and MVO
and the frequent appearance of both phenomena together
with IMH. Surprisingly, an intake of beta-blockers demon-
strated the highest OR for the occurrence of IMH. However,
there was neither a significant difference between IMH+
and IMH− patients according to the presence of arterial
hypertension, nor a tendency toward higher systolic or
diastolic blood pressure in the IMH+ group. However, in
the IMH+ group more patients were on a combined antihy-
pertensive drug therapy with beta-blockers as compared to
the IMH− group.
Discussion
In our large study (n=151) we could demonstrate the impor-
tance of using dedicated T2









Fig. 4 Venn diagram of the frequency of IMH, MVO and HIC out of the
basic population. It demonstrates the occurrence of IMH without MVO
and/or HIC. CMR cardiovascular magnetic resonance, IMH
intramyocardial haemorrhage, MVO microvascular obstruction, HIC
hypointense core in T2-STIR
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detect IMH after acute reperfused STEMI to definitely distin-
guish IMH fromMVO. In some cases IMH could be detected
even without a visible MVO (Fig. 2), which is in contrast to
several other studies [5, 6, 11, 31, 32]. Our data indicate that
T2-STIR sequences only, which are generally used to visualise
AAR and MSI, are not able to reliably detect IMH as a HIC
within the oedema. Furthermore, potential influencing factors
for the occurrence of IMH could be evaluated.
Our most important findings can be summarized as
follows:
1. IMH is a common finding in patients with acute STEMI
after PPCI and was present in approximately 50 % of our
patients.
2. Our data demonstrated that the majority of T2
* defects
were also defects on T2 imaging (HIC), but some T2
defects had had no defect on T2
* imaging. Although not
directly proven by our works, experimental studies sug-
gest [33–36] that T2
* imaging is more accurate for IMH
than T2 imaging and therefore should be the preferred
technique for detection of IMH.
3. However, according to the multivariate analysis HIC on T2
imaging and MVO on LGE images are highly correlated
with occurrence of defect on T2
* images indicating IMH.
CMR after reperfused STEMI and the role of the used
sequences
CMR is considered as the gold standard for the assessment of
ventricular volumes and mass [28, 37] as well as in patients
with acute reperfused myocardial infarction as the preferred
method for the noninvasive evaluation of viability, infarct size
and myocardial salvage with a high prognostic value [5, 38,
39]. The prognostic value of MVO and IMH after acute
reperfused myocardial infarction has previously been de-
scribed [5, 11, 16]. However, there is disagreement in the
literature about the best CMR sequences to detect IMH
[5, 7, 10, 11, 15, 30, 33–36, 38, 40, 41] and how to
definitely differentiate it from MVO.
Pedersen et al. demonstrated in an animal study that T1-
weighted sequences are more accurate than T2- or T2
*-weight-
ed sequences for the detection of IMH [40]. In contrast to this
study Bradley and Kali et al. [17, 34] showed the highest
sensitivity for IMH detection by using T2
*-weighted CMR
sequences, which is in line with previous data in neuroradiol-
ogy [17, 18, 42] and animal models using T2
* mapping in the
heart [10]. Lotan et al. declared difficulties in the detection of
Table 2 Differences in the
detection of HIC and MVO in
IMH+ versus IMH− patients
Data are reported as number
(percentage)









HIC+ (STIR), n (%) 64 (84) 18 (24) <0.001
HIC− (STIR), n (%) 12 (16) 57 (76) <0.001
MVO+ (3D-IR-GRE), n (%) 72 (95) 28 (37) <0.001
MVO− (3D-IR-GRE), n (%) 4 (5) 47 (63) <0.001
Fig. 5 Relationship between TIMI flow before PPCI ≤1 and haemorrhage:
In IMH+ patients a TIMI flow ≤1 before PPCI was significantly more
frequent than in IMH− patients (71 % vs. 51 %, P<0.001), which could be
considered as a potential influencing factor for the development of IMH
p < 0.001






















Fig. 6 Relationship between infarct size and haemorrhage: the IMH
group had significantly larger mean infarct sizes (32.6±20.3 ml vs.
12.9±9.5 ml, P<0.001) at the LGE sequences
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haemorrhage by using T2-weighted images only. That study
group stated that the reciprocal influencing effects of the
hyperintense oedema and HIC may mask IMH [31]. Further-
more, a postmortem study by Jackowski et al. [35] demon-
strated that MVO without haemorrhage and HIC on T2-
weighted images exist.
Nevertheless, there is a strong relationship between the
occurrence of IMH and MVO [41]. Also this study demon-
strated MVO in 95 % of patients with IMH.
But it has also been described before that some patients
may exclusively present IMH or MVO [38]. In the current
study 5 % of patients with IMH did not show any MVO.
Therefore, we suppose that T2
*-weighted sequences could
detect small amounts of haemorrhage with a very high
sensitivity, despite a slightly lower spatial resolution as com-
pared to the T2-STIR, but also only slightly higher than the
LGE sequences.
However, in previous studies and also in our study it could
not definitely be clarified if IMH can be present without MVO
and further studies are still needed to examine this finding.
Prior analysis had demonstrated that T2
*-weighted sequences
in particular can reliably detect even small amounts of cerebral
haemorrhage [18, 42, 43]. But the spatial resolution of the
presently used LGE sequences may not be high enough to
depict every MVO, while the corresponding T2
*-weighted
sequences do for the detection of IMH. The spatial resolution
of the T2
* sequence in our study was slightly higher than the
spatial resolution of the LGE sequence.
Nevertheless, artefacts are common on T2
*-weighted im-
ages and could mimic IMH. To reduce this potential source of
misinterpretation a hypointense signal on the T2
* images was
only defined as IMH if the decay on the parameter image was
at most 20 ms as previously described [16]. In another study
an even more sensitive threshold with a T2
* decay of less than
30mswas proposed [32], which may additionally increase the
number of IMH+ patients without any visible MVO or HIC.
The occurrence of IMH without MVO on the LGE images
may also be caused by passive diffusion of contrast agent into
































Fig. 7 Relationship between myocardial salvage index and haemor-
rhage. MSI in the IMH group was significantly lower than in the non-
IMH group (0.36±0.21 vs. 0.59±0.25, P<0.001)
Table 3 CMR results
















LVejection fraction (%) 47±10 43±10 51±9 <0.001 19.6 0.912 0.876–0.950
LVend-diastolic volume, ml 154±37 163±40 145±30 0.003 8.2 1.01 1.000–1.020
LVend-systolic volume, ml 83±32 94±36 72±23 <0.001 15.5 1.03 1.010–1.040
LV stroke volume, ml 71±16 69±15 73±15 0.07 3.2 0.981 0.960–1.002
Infarct size absolute, ml 23±19 33±20 13±9 <0.001 33.5 1.13 1.080–1.170
Myocardial salvage index (MSI) 0.47±0.26 0.36±0.21 0.59±0.25 <0.001 25.2 0.014 0.003–0.073
Volume of HIC at STIR, ml 2.3±4.3 4.2±5.4 0.3±0.8 <0.01 9.18 4.67 1.730–12.90
HIC at STIR, n (%) 82 (54) 64 (84) 18 (24) <0.001
Volume of MVO at 3D-IR-GRE, ml 3.1±6.5 5.8±8.3 0.4±0.9 <0.001 27.7 3.62 2.240–5.850
MVO present at 3D-IR-GRE, n (%) 100 (66) 72 (95) 28 (37) <0.001
Data are reported as mean±SD or mean (minimum–maximum) if continuous and number (percentage) if categorical
OR odds ratio, CI confidence interval
Table 4 Characteristics associated with IMH/predictors of IMH
Variable Odds ratio (95 % CI) P value multivariate
Volume of MVO (ml) 4.1 (1.4–12.3) 0.01
Volume of HIC (ml) 2.9 (1.8–4.8) <0.001
Beta-blocker at admission 4.6 (1.6–13.1) 0.004
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the small infarct core, obscuring the presence of MVO on the
LGE images [44].
Furthermore, it is not yet understood what a HIC in T2-
weighted STIR sequences represents when IMH and MVO
could not be demonstrated (2 % (3/151) of all patients in this
study). In one of only a few histologically confirmed post-
mortem analyses [35] HIC always represented MVO with or
without IMH.
Relationship between IMH and potential influencing factors
Previous publications and this study confirmed that IMH is
not always detectable in patients after acute reperfused
STEMI. In about half of our patients IMH was detectable,
which is consistent with findings from Beek et al. with 49 %
of patients with IMH [3] or Robbers et al. with 60 % [44], but
much more frequent as described in other studies [5, 45].
Therefore, potentially influencing factors for the occurrence
of IMH should be evaluated. In our study most patients with
IMH showed an occluded LAD (50 %) and patients without
IMH presented more often an occluded RCA, which had
already been described by Amabile et al. [45]. The majority
of our patients (42 %) had their culprit lesion in the LAD
territory (Table 1) and the IMH+ mostly in the proximal
segment (50 % vs. 38 %), whereas in the LCX it was mainly
located at the middle segment, with an equal distribution
within both groups. The second most involved territory was
the RCA region (39 %), in which the IMH+ demonstrated an
almost equal distribution of proximally and distally located
lesions. But in the IMH− group the culprit lesion was mainly
located proximally in more than 50 % of patients. Infarct size
roughly correlates with the location of the culprit lesion and a
proximal lesion in the LAD territory causes usually larger
infarcts than a proximal lesion in the RCA. Furthermore,
IMH correlated significantly with infarct size.
Patients with a low TIMI flow before PPCI (≤1) seem to
have a higher risk for the development of IMH (Fig. 5).
Seventy-two per cent of our patients with a TIMI flow grade
≤1 demonstrated an IMH, which was significantly different to
those patients without IMH. Similar results could be demon-
strated in prior studies, e.g. Eitel et al. reported on 87 %
patients with a TIMI flow grade≤1 before PPCI [5] and a
HIC, which was used as an indicator for IMH in this study.
Nevertheless, in the final multivariate analysis (Table 4) only
HIC and especially MVO were significant predictors of IMH.
Furthermore, the beta-blocker intake at admission was a
strong predictor of IMH in patients. In the IMH+ group more
patients were on a combined antihypertensive therapy indicat-
ing a potentially more severe arterial hypertension, but this is
rather speculative and has to be proven using another study
design. However, several large trials on the use of beta-
blockers in myocardial infarction demonstrated that the use
of beta-blockers reduced the risks of reinfarction and
ventricular fibrillation, but increased the risk of cardiogenic
shock [46, 47]. These findings changed the clinical practice of
beta-blocker use in patients presenting with acute coronary
syndromes, emphasizing the potential harm of beta-blockers
in patients at increased risk of cardiogenic shock. Neverthe-
less, this unexpected finding may also be an epiphenomenon.
Relationship between IMH and ventricular function
Other studies have already demonstrated the relationship be-
tween the presence of IMH and significantly larger infarct
sizes, decreased left ventricular function, less myocardial sal-
vage and an adverse prognosis [3, 5, 11]. IMH after STEMI is
seen as a reperfusion injury and closely related to larger infarct
sizes [5]. In this study we confirmed a significantly lower LV-
EF, larger LV-EDV and LV-ESV and larger infarct sizes in
patients with IMH. These findings were also seen in studies by
Eitel et al. and Beek et al. [3, 5, 44]. Beek et al. did not find
any prognostic influence of MVO [3]. O’Regan et al. sup-
posed that the occurrence of IMH is related to a reduced
myocardial salvage [16]. In our patients a significant impact
of IMH on ventricular function and volumes could be dem-
onstrated, therefore it might be considered to be a potentially
important prognostic factor.
Limitations
This is a retrospective study on limited patients with acute
reperfused ST-elevation myocardial infarction. A prospective
study on a bigger study cohort would be desirable to confirm
our results and even more important to confirm the prognostic
significance of IMH in this group of patients.
As a result of time constraints in this study, like in others
[16], we used only one single slice T2
* mapping sequence in
the most representative slice in the middle of the myocardial
oedema. An additional retrospective analysis of our data re-
vealed that that was always in agreement with the centre of the
LGE area. More slices could not be acquired and therefore
possible haemorrhage in other areas might be missed. There-
fore, it can be considered that the frequency of IMH is prob-
ably even higher than described in the present study. Further
studies should therefore use a whole heart T2
* mapping ap-
proach.We also could not compare the total size of IMH to the
size of HIC or MVO because of the one single slice T2
*
mapping.
The period of time after infarction at which CMR was
performed could also have been an important influencing
factor for the IMH detection rate, because of the different
degradation stages of haemoglobin, which have an effect on
the signal intensity [17, 48, 49]. In this study the CMR
analysis was performed within 8 days after infarction (mean
2.8 days). It is known that the oxyhaemoglobin of fresh
bleeding does not have any paramagnetic effect and therefore
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can not be detected by T2
*-weighted MRI. As a result of
oxidative denaturation, deoxyhaemoglobin with its detectable
paramagnetic effects occurs usually after 12–72 h, which is
known from cerebral MRI studies [48]. Therefore, it can be
hypothesised that in these patients additional haemorrhage
may have been detected if MR imaging had been performed
later. In addition to that, Kali et al. described the good
commitment of T2
*-weighted CMR for the assessment of
changes in iron deposition in postinfarcted myocardium [33,
34]. The paramagnetic effects of iron are still visible on T2
*-
weighted images after months.
Conclusions
IMH is a frequent finding in reperfused STEMI associated
with reduced ventricular function and myocardial damage,
which can be assessed by CMR. Our data indicates—in con-
cordance with other recently published data [33–36]—that T2
*
mapping seems to be more suitable than T2-weighted images
alone for the detection of IMH in reperfused acute myocardial
infarction. Despite the fact that it is rather closely correlated
with a HIC in T2-weighted images and MVO in LGE images,
it can also occur alone according to our results.
In a larger trial with additional follow-up examinations and
especially the use of a full left ventricular coverage of T2
*
mapping, it has to be proven if this is really a separate
phenomenon to MVO with a clinical and prognostic impact
or just another possibility to detect MVO with a higher sensi-
tivity as compared to T2-weighted STIR and LGE sequences.
However, this may allow for a better risk stratification in
patients after acute reperfused myocardial infarction.
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